Standard BioTools (LAB) CEO Michael Egholm Surrenders 97,627 Shares

What Happened
Michael Egholm, President & CEO and a director of Standard BioTools, had 97,627 shares withheld (disposed) on August 20, 2026 to satisfy tax withholding obligations tied to the vesting of restricted stock units. The withholding was reported at $0.67 per share for a total value of $65,605. This was a tax-withholding disposition (transaction code F), not an open-market sale.

Key Details

• Transaction date: August 20, 2026; filing date: August 24, 2026 (appears timely within the required reporting window).
• Shares withheld/disposed: 97,627 at $0.67 per share; total value ~$65,605.
• Shares owned after transaction: not specified in the excerpt of the filing provided.
• Footnote: Shares were withheld to satisfy tax withholding on RSUs that vested from grants dated May 20, 2024; March 21, 2025; and March 20, 2026 (those grants were originally reported on Forms 4 filed May 21, 2024; March 24, 2025; and April 8, 2026).
• Transaction code meaning: F = payment of exercise price or tax liability (here, tax withholding).

Context
Withheld-share transactions to cover taxes on vested awards are routine and do not represent a deliberate open-market sale by the insider. They typically do not signal a change in the insider’s view of the company’s prospects; instead, they are a common administrative step when equity awards vest.